Correction to: Scientific Reports 10.1038/s41598-020-66688-1, published online 30 June 2020
This Article contains errors in the average and standard deviation calculations of postoperative weight patients for the effect of Roux-en-Y gastric bypass reported in Table 1.
The ‘Weight (kg)’ value for ‘Postoperative’ patients ‘With cholecystectomy (n = 7),’
“112.3 ± 10.89”
should read:
“95 ± 10.55”
Additionally, the ‘Weight (kg)’ value for ‘Postoperative’ patients ‘Without cholecystectomy (n = 21),’
“108.17 ± 14.50”
should read:
“90.7 ± 12.40”
The correct Table 1 appears below:
Table 1.
A corrected version of Table 1. Data are expressed by mean ± standard deviation, except the data on insulin levels, which are expressed as median (interquartile ranges). Bold p values highlight the clinical variables that responded to RYGB at different significant levels in patients with or without cholecystectomy. BMI, body mass index; HbA1c%, glycated hemoglobin; HDL, high density lipoproteins; LDL, low density lipoproteins; VLDL, very low-density lipoproteins.
| Variables | With cholecystectomy (n = 7) | Without cholecystectomy (n = 21) | ||||
|---|---|---|---|---|---|---|
| Preoperative | Postoperative | p value | Preoperative | Postoperative | p value | |
| Weight (kg) | 117.28 ± 13.10 | 95 ± 10.55 | < 0.050 | 111.81 ± 16.20 | 90.7 ± 12.40 | < 0.050 |
| BMI (kg/m2) | 47.00 ± 4.60 | 45.80 ± 3.90 | < 0.050 | 44.40 ± 6.00 | 43.00 ± 5.30 | < 0.050 |
| % Body Fat | 50.30 ± 9.70 | 48.77 ± 4.70 | 0.937 | 51.83 ± 5.50 | 43.51 ± 6.30 | < 0.050 |
| % Lean mass | 49.60 ± 9.70 | 51.22 ± 4.70 | 0.219 | 48.17 ± 5.50 | 56.49 ± 6.30 | < 0.050 |
| Body fat (kg) | 59.10 ± 15.30 | 46.47 ± 8.00 | 0.469 | 57.96 ± 13.16 | 39.44 ± 9.90 | < 0.050 |
| Lean mass (kg) | 56.90 ± 7.80 | 48.53 ± 5.90 | 0.297 | 52.93 ± 6.80 | 50.16 ± 5.90 | < 0.050 |
| Glucose (mg/dL) | 195.40 ± 89.20 | 102 ± 27.70 | < 0.050 | 223.76 ± 67.80 | 102.68 ± 18.90 | < 0.050 |
| Insulin (µU/mL) | 18.10 (13.50–20.90) | 7.8 (6.30–16.70) | < 0.050 | 16.30 (13.45–25.40) | 7.9 (6.90–12.70) | < 0.050 |
| %HbA1c | 8.30 ± 1.90 | 5.9 ± 0.50 | < 0.050 | 9.08 ± 1.50 | 6.01 ± 0.40 | < 0.050 |
| C peptide (ng/mL) | 3.60 ± 0.90 | 2.64 ± 0.57 | 0.109 | 4.21 ± 1.40 | 3.01 ± 0.97 | < 0.050 |
| Cholesterol total (mg/dL) | 178.10 ± 42.10 | 151.28 ± 27.00 | 0.297 | 200.71 ± 32.40 | 166.84 ± 56.50 | < 0.050 |
| HDL (mg/dL) | 40.20 ± 11.08 | 44.14 ± 11.60 | 0.202 | 44.81 ± 9.35 | 42.10 ± 8.90 | < 0.050 |
| LDL (mg/dL) | 108.80 ± 36.50 | 87.85 ± 22.10 | 0.352 | 121.57 ± 33.62 | 101.2 ± 43.65 | < 0.050 |
| VLDL (mg/dL) | 29.00 ± 9.90 | 19.28 ± 3.30 | 0.156 | 29.58 ± 9.67 | 23.52 ± 10.54 | 0.078 |
| Triglycerides (mg/dL) | 145.10 ± 49.00 | 96.42 ± 16.80 | 0.156 | 175.5 ± 103 | 117.94 ± 52.70 | < 0.050 |